专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO1997005228A1 METHOD FOR TREATING SURFACE OF SUBSTRATE AND SURFACE TREATMENT COMPOSITION THEREFOR 审中-公开
标题翻译：用于处理基材表面和表面处理组合物的方法
公开(公告)号：WO1997005228A1
公开(公告)日：1997-02-13
申请号：PCT/JP1996002077
申请日：1996-07-25
申请人： MITSUBISHI CHEMICAL CORPORATION , MORINAGA, Hitoshi , FUJISUE, Masaya
发明人： MITSUBISHI CHEMICAL CORPORATION
IPC分类号： C11D07/04
CPC分类号： H01L21/02054 , C11D3/3947 , C11D7/06 , C11D7/261 , C11D7/263 , C11D7/264 , C11D7/265 , C11D7/266 , C11D7/267 , C11D7/32 , C11D7/3227 , C11D7/3245 , C11D7/34 , C11D11/0047 , H01L21/02052
摘要： A method for treating the surface of a substrate with a surface treatment composition, wherein the surface treatment composition comprises a liquid medium containing a complexing agent as a metal deposition preventive, the complexing agent comprising at least one member selected from the following: (group A) complexing agents and at least one member selected from the group consisting of the following: (groups B1 to B6) complexing agents: (group A) complexing agents having an aromatic hydrocarbon ring in the molecular structure thereof and an OH group and/or an O- group bonded directly to a carbon atom consisting of the ring; (group B1) complexing agents having a nitrogen atom as a donor atom in the molecular structure thereof; (group B2) complexing agents having in the molecular structure thereof at least one donor atom selected from halogen, sulfur and carbon atoms; (group B3) complexing agents having an oxygen atom as a donor atom in the molecular structure thereof; (group B4) carboxylic acid complexing agents having a carboxyl group in the molecular structure thereof; (group B5) hydroxy mono- or dicarboxylic acid complexing agents having four or less hydroxyl groups in the molecular structure thereof; and (group B6) complexing agents having a carbonyl group in the molecular structure thereof.
摘要翻译：一种用表面处理组合物处理基材表面的方法，其中所述表面处理组合物包含含有作为金属沉积预防剂的络合剂的液体介质，所述络合剂包含选自以下的至少一种：（组A ）络合剂和选自以下的至少一种：（组B1至B6）络合剂：（组A）在其分子结构中具有芳族烃环的OH基和/或 O-基直接键合到由环组成的碳原子上; （B1组）在其分子结构中具有氮原子作为供体原子的络合剂; （组B2）在其分子结构中具有至少一个选自卤素，硫和碳原子的供体原子的络合剂; （B3组）在其分子结构中具有氧原子作为供体原子的络合剂; （B4族）羧酸络合剂，其分子结构中具有羧基; （B5组）在其分子结构中具有四个或更少羟基的羟基单羧酸或二羧酸络合剂; 和（B6族）在其分子结构中具有羰基的络合剂。

2. 发明申请

WO1998022986A2 LITHIUM ION ELECTROLYTIC CELL AND METHOD FOR FABRICATING SAME 审中-公开
标题翻译：锂离子电解电池及其制造方法
公开(公告)号：WO1998022986A2
公开(公告)日：1998-05-28
申请号：PCT/IB1997001664
申请日：1997-11-13
申请人： MITSUBISHI CHEMICAL CORPORATION
发明人： MITSUBISHI CHEMICAL CORPORATION , FAUTEUX, Denis, G. , SHI, Jie , MASSUCCO, Arthur, A.
IPC分类号： H01M00/00
CPC分类号： H01M4/13 , H01M4/62 , H01M4/621 , H01M10/0525 , Y10T29/49115
摘要： The present invention relates to secondary electrolytic cells, and more particularly, to lithium ion electrolytic cells with an inorganic binder and an associated process for fabrication of same. A binder material is mixed with an active material for eventual application onto the surface of a first and/or second electrode. The binder material is soluble with the active material yet insoluble with respect to the associated organic electrolyte.
摘要翻译：本发明涉及二次电解槽，更具体地涉及具有无机粘合剂的锂离子电解槽和相应的制造方法。粘合剂材料与活性材料混合，以允许可能施加到第一和/或第二电极的表面。粘合剂材料可与活性材料溶解，而不溶于相关的有机电解质。

3. 发明申请

WO1998015269A1 DRUGS CONTAINING ROTENOIDS 审中-公开
标题翻译：含有ROTENOIDS的药物
公开(公告)号：WO1998015269A1
公开(公告)日：1998-04-16
申请号：PCT/JP1997003587
申请日：1997-10-07
申请人： MITSUBISHI CHEMICAL CORPORATION , TAKASHIMA, Junko , CHIBA, Noriko
发明人： MITSUBISHI CHEMICAL CORPORATION
IPC分类号： A61K31/35
CPC分类号： C07D493/14
摘要： Drugs containing as the active ingredient rotenoids represented by general formula (1) wherein R and R represent each hydroxy, C1-3 alkoxy, etc.; R and R represent each hydrogen, C1-6 alkyl or C2-6 alkenyl; R represents hydroxy, C1-3 alkoxy, etc.; R and R represent each hydrogen, hydroxy or C1-3 alkoxy; X represents -C(=O)-, etc.; and Y represents -CH(R)- (wherein R represents hydrogen, hydroxy or C1-3 alkoxy), etc. These drugs exert antibacterial effects specifically on microorganisms belonging to the genus Helicobacter, such as H. pylori, and are usable in the treatment of gastric ulcer, gastric cancer, etc.
摘要翻译：含有由通式（1）表示的活性成分旋转体的药物，其中R 2和R 3代表每个羟基，C 1-3烷氧基等; R 8和R 10代表每个氢，C 1-6烷基或C 2-6烯基; R 9表示羟基，C 1-3烷氧基等; R 11和R 12a代表每个氢，羟基或C 1-3烷氧基; X表示-C（= O） - 等; 并且Y表示-CH（R） - （其中R表示氢，羟基或C 1-3烷氧基）等。这些药物特异性地对幽门螺杆菌属的幽门螺杆菌属微生物具有抗菌作用，可用于治疗胃溃疡，胃癌等

4. 发明申请

WO1998003434A1 DEVICE FOR CONTROLLING DISSOLVED OXYGEN CONCENTRATION OF AERATION TANK, DEVICE FOR CONTROLLING TEMPERATURE OF AERATION TANK, DEVICE FOR CONTROLLING FLOW RATE OF RAW WATER FOR HOMOGENEOUS-FLOW LIQUID SURFACE, AND WASTEWATER TREATMENT EQUIPMENT USED IN ACTIVATED SLUDGE PROCESS 审中-公开
标题翻译：控制气罐氧化浓度的装置，用于控制气罐温度的装置，用于控制均匀流动液面的原水流量的装置和用于活化淤泥过程中的废水处理装置
公开(公告)号：WO1998003434A1
公开(公告)日：1998-01-29
申请号：PCT/JP1997002514
申请日：1997-07-18
申请人： MITSUBISHI CHEMICAL CORPORATION , MILLER, Randy, M. , UDA, Akifumi , ITOYAMA, Kazutoshi , YAMAMOTO, Yoshiaki
发明人： MITSUBISHI CHEMICAL CORPORATION
IPC分类号： C02F03/12
CPC分类号： C02F3/006 , C02F2209/02 , C02F2209/22 , C02F2209/40 , C02F2209/42 , Y02W10/15
摘要： In wastewater treatment equipment utilizing the activated sludge process in a comprehensive wastewater treatment plant and a sewage treatment plant of chemical factories or the like, wastewater is treated in a stabilized manner controlled so as to prevent excessive or insufficient feed of oxygen and to keep the concentration of dissolved oxygen in the tank constant by receiving a signal from a dissolved oxygen analyzer (5) by means of a predictive-PID control unit (11), predicting the behavior of the dissolved oxygen concentration by using the control data in the past and a dynamic behavior model for the controlled system, comparing the predicted value with the target value of the dissolved oxygen concentration, and adjusting the feed rate of oxygen to reduce the deviation.
摘要翻译：在综合污水处理厂和化工厂等的污水处理厂利用活性污泥处理的污水处理设备中，以稳定化的方式处理废水，以防止过量或不足的氧气供应并保持浓度通过借助于预测PID控制单元（11）接收来自溶解氧分析仪（5）的信号来确定罐中的溶解氧的常数，通过使用过去的控制数据来预测溶解氧浓度的行为，以及控制系统的动态行为模型，将预测值与溶解氧浓度的目标值进行比较，并调整氧气的进料速率以减少偏差。

5. 发明申请

WO1997049007A1 PIGMENT COMPOSITION FOR LIQUID TONER, METHOD OF MANUFACTURING THE SAME AND LIQUID TONER MANUFACTURING METHOD 审中-公开
标题翻译：液体色粉的颜料组合物，其制造方法和液体制备方法
公开(公告)号：WO1997049007A1
公开(公告)日：1997-12-24
申请号：PCT/JP1997002114
申请日：1997-06-19
申请人： MITSUBISHI CHEMICAL CORPORATION , MITSUBISHI HEAVY INDUSTRIES, LTD. , HISASHI, Hideyuki , MATSUGI, Akihiro , SUDA, Yasuharu , KUNO, Hiroaki , MAKINO, Katsuaki
发明人： MITSUBISHI CHEMICAL CORPORATION , MITSUBISHI HEAVY INDUSTRIES, LTD.
IPC分类号： G03G09/12
CPC分类号： G03G9/125 , G03G9/122
摘要： A pigment composition for liquid toner which is prepared by dissolving/dispersing carbon black and a resin in a nonaqueous solvent. One of (1) carbon black containing not more than 10 ppm of grit and not more than 0.1 wt.% of ash, (2) carbon black in which the quotient of the division of the total quantity of oxygen determined on the basis of a 1500 DEG volatile component by the specific surface area is 0.20-0.40 mg/m , and (3) carbon black in which the content of polycyclic aromatic hydrocarbons in a liquid extracted by using monochlorobenzene is not more than 30 ppm, is used as the carbon black. The pigment composition is manufactured by kneading a pigment and a resin, freeze-pulverizing the resultant product, and then dissolving/dispersing the powder in a nonaqueous solvent. Thus a pigment composition for liquid toner enabling excellent image characteristics, especially, image characterisitics with a sufficiently high printing density, and a pigment composition for liquid toner exerting little influence upon a living body even if it is inhaled and having excellent image characteristics are provided.
摘要翻译：通过将炭黑和树脂溶解/分散在非水溶剂中而制备的用于液体调色剂的颜料组合物。（1）炭黑中含有不大于10ppm的砂粒和不超过0.1重量％的灰分，（2）炭黑，其中基于a确定的氧气总量除数的商 1500份挥发性成分的比表面积为0.20-0.40mg / m 2，（3）使用一氯苯萃取的液体中多环芳烃的含量不超过30ppm的碳黑作为炭黑。颜料组合物通过捏合颜料和树脂，将所得产物冷冻粉碎，然后将粉末溶解/分散在非水溶剂中来制备。因此，提供了具有优异的图像特性，特别是具有足够高的印刷密度的图像特征的液体调色剂用颜料组合物，以及即使吸入并且具有优异的图像特性对活体几乎没有影响的液体调色剂的颜料组合物。

6. 发明申请

WO1997048271A1 MEDIA FOR THE TISSUE CULTURE OF PLANTS AND METHOD OF CULTURE WITH THE SAME 审中-公开
标题翻译：植物组织培养基及其培养方法
公开(公告)号：WO1997048271A1
公开(公告)日：1997-12-24
申请号：PCT/JP1997002088
申请日：1997-06-18
申请人： NISSHINBO INDUSTRIES INC. , MITSUBISHI CHEMICAL CORPORATION , HASEGAWA, Osamu , TADOKORO, Fumihiko , TAKAHASHI, Nobumitsu
发明人： NISSHINBO INDUSTRIES INC. , MITSUBISHI CHEMICAL CORPORATION
IPC分类号： A01H04/00
CPC分类号： A01H4/001
摘要： Materials for media to be used for efficiently effecting the proliferation and acclimatization of plants to be tissue-cultured to thereby give mature seedlings; a process for producing these materials; and a culture method characterized by using these media. The tissue culture media are characterized by containing vermiculite having an average grain size of 0.1 to 10 mm and cellulose fibers having an average fiber length of 0.01 to 5 mm. In the culture method, the above medium is used in a light-transmittable container at least partly covered with a porous film having a gas permeability (air permeability: JIS P 8117) of, preferably, 1 to 50 sec/100 ml. By using a medium produced by molding a mixture of a specific vermiculite with cellulose fibers, the culture can be efficiently carried out with good handling characteristics and good rooting and growth can be achieved. Thus, good seedlings can be obtained by a single culture without resort to acclimatization. Moreover, these seedlings can be transplanted and grown as such in the soil for raising the same outside without damaging the roots. Combined use of the medium with a gas-permeable container makes these effects further remarkable.
摘要翻译：用于有效影响待组织培养的植物的增殖和驯化的培养基的材料，从而产生成熟的幼苗; 一种生产这些材料的方法; 以及使用这些培养基的培养方法。组织培养基的特征在于含有平均粒径为0.1〜10mm的蛭石和平均纤维长度为0.01〜5mm的纤维素纤维。在培养方法中，将上述培养基用于至少部分被透气性（透气度：JIS P 8117）的多孔膜覆盖的透光性容器中，优选为1〜50秒/ 100ml。通过使用通过将特定蛭石的混合物与纤维素纤维成型而制备的介质，可以有效地进行培养，具有良好的处理特性，并且可以实现良好的生根和生长。因此，通过单一培养可以获得良好的幼苗，而不需要适应环境。此外，这些幼苗可以在土壤中移植和生长，以便在不损害根部的情况下提高相同的外部。将介质与气体渗透性容器结合使用，使这些效果更加显着。

7. 发明申请

WO1996037463A1 PROCESS FOR PRODUCING N-METHYLMETHOXYIMINOACETAMIDE DERIVATIVES AND INTERMEDIATES THEREFOR 审中-公开
标题翻译：生产N-甲基甲酰胺酰胺衍生物及其中间体的方法
公开(公告)号：WO1996037463A1
公开(公告)日：1996-11-28
申请号：PCT/JP1996001349
申请日：1996-05-22
申请人： MITSUBISHI CHEMICAL CORPORATION , ODA, Masatsugu , KATSURADA, Manabu
发明人： MITSUBISHI CHEMICAL CORPORATION
IPC分类号： C07C251/48
CPC分类号： C07C249/12
摘要： A process for producing an N-methyl-methoxyiminoacetamide derivative represented by general formula (III), wherein R represents hydrogen, etc., which comprises reacting a novel 1-alkoxy-4-methoxyimino-2-methyl-3-oxo-1,2,3,4-tetrahydroisoquinoline derivative represented by formula (I), wherein R represents C1-4 alkyl, with an oxyamine derivative represented by the following general formula (II): H2NO-R , wherein R is as defined above.
摘要翻译：一种制备由通式（III）表示的N-甲基 - 甲氧基亚氨基乙酰胺衍生物的方法，其中R 2表示氢等，其包括使新的1-烷氧基-4-甲氧基亚氨基-2-甲基-3-氧代由式（I）表示的1,2,3,4-四氢异喹啉衍生物，其中R 1表示C 1-4烷基，和由以下通式（II）表示的氧胺衍生物：H 2 NO-R 2，其中R 2如上所定义。

8. 发明申请

WO1996032960A1 PREVENTIVE AND/OR REMEDY FOR ISCHEMIC DISEASES 审中-公开
标题翻译：预防和/或补救疾病
公开(公告)号：WO1996032960A1
公开(公告)日：1996-10-24
申请号：PCT/JP1996001065
申请日：1996-04-19
申请人： MITSUBISHI CHEMICAL CORPORATION , GEMBA, Munekazu , YONEHANA, Tsutomu
发明人： MITSUBISHI CHEMICAL CORPORATION
IPC分类号： A61K38/18
CPC分类号： A61K38/1833
摘要： A preventive and/or remedy for ischemic diseases containing as the active ingredient a hepatic parenchymal cell growth factor, for example, a proteinous factor with the following physicochemical properties: 1) having a molecular weight deduced from SDS-PAGE of about 76 to 92 kD; 2) having the activity of proliferating hepatic parenchymal cells; 3) this activity being lost by heating at 80 DEG C for 10 minutes; 4) this activity being lost by digesting with trypsin or chymotrypsin; 5) having a high affinity for heparin; etc. HGF employed as the active ingredient exerts the effect of suppressing cytotoxicyty in an ischemic model and, therefore, is efficacious as a preventive and/or remedy for ischemic diseases.
摘要翻译：含有作为活性成分的肝实质细胞生长因子，例如具有以下物理化学性质的蛋白质因子的缺血性疾病的预防和/或补救措施：1）从SDS-PAGE推导的分子量为约76至92kD ; 2）具有增殖性肝实质细胞活性; 3）此活动在80℃下加热10分钟; 4）通过用胰蛋白酶或胰凝乳蛋白酶消化而损失该活性; 5）对肝素具有高亲和力; 作为活性成分的HGF在缺血模型中发挥抑制细胞毒素作用，因此作为缺血性疾病的预防和/或补救有效。

9. 发明申请

WO1996024844A1 METHOD OF DIAGNOSING IMMUNE DISEASES 审中-公开
标题翻译：诊断免疫疾病的方法
公开(公告)号：WO1996024844A1
公开(公告)日：1996-08-15
申请号：PCT/JP1996000282
申请日：1996-02-09
申请人： IDEC PHARMACEUTICALS CORPORATION , MITSUBISHI CHEMICAL CORPORATION , OHGAKI, Makoto , TAKASAKI, Yoshinari
发明人： IDEC PHARMACEUTICALS CORPORATION , MITSUBISHI CHEMICAL CORPORATION
IPC分类号： G01N33/53
CPC分类号： G01N33/56972 , G01N33/56977
摘要： A method of diagnosing immune diseases which comprises the step of immunologically determining the CD80 antigen-positivity rate of the lymphocytes and/or lymphocyte subgroups contained in a body fluid sample separated from man by using, for example, an antihuman CD80 monoclonal antibody that recognizes CD80 antigens. The method is characterized in that it permits various immune diseases to be diagnosed readily and accurately and that, as compared with conventional diagnostic methods, it is simple in operation and does not much burden the patients because the object to be detected is lymphocytes contained in body fluids, such as peripheral blood, readily sampled from them. The invention also provides a medicine which contains as the active ingredient antihuman CD80 antibodies that specifically recognize human CD80 antigens and which can ameliorate or prevent immune disorder in a disease-specific way.
摘要翻译：一种诊断免疫疾病的方法，包括以下步骤：通过使用例如识别CD80的抗人CD80单克隆抗体免疫测定与人分离的体液样品中所含的淋巴细胞和/或淋巴细胞亚群的CD80抗原阳性率抗原。该方法的特征在于可以容易且准确地诊断各种免疫疾病，并且与常规诊断方法相比，其操作简单，对患者的负担不大，因为待检测的对象是体内淋巴细胞流体，如外周血，很容易从中抽取。本发明还提供一种药物，其含有特异性识别人CD80抗原的抗人CD80抗体作为活性成分，其可以以疾病特异性方式改善或预防免疫疾病。

10. 发明申请

WO1996021056A1 FIBER, FILM, BIOABSORBABLE SURGICAL SUTURE AND BIOABSORBABLE ADHESION INHIBITOR EACH COMPRISING BIOCOMPATIBLE BLOCK COPOLYMER 审中-公开
标题翻译：纤维，膜，生物可吸收的外科手术和生物可溶性粘合抑制剂，每个包含生物可调性嵌段共聚物
公开(公告)号：WO1996021056A1
公开(公告)日：1996-07-11
申请号：PCT/JP1995002726
申请日：1995-12-27
申请人： MITSUBISHI CHEMICAL CORPORATION , KIMURA, Yoshiharu , YAMAOKA, Tetsuji
发明人： MITSUBISHI CHEMICAL CORPORATION
IPC分类号： D01F06/84
CPC分类号： C08J5/18 , A61L17/12 , A61L31/00 , C08J2367/02 , D01F6/86
摘要： A fiber and a film comprising a block copolymer represented by general formula (1) and having a weight-average molecular weight of 25,000 to 500,000, wherein R represents hydrogen or methyl; 1 represents a number of 1 or above; and m, m', n and n' are the same or different and each represents 0 or a number of 1 or above, provided that m + m' is not 0 and n + n' is not 0. When processed into a monofilament, the block copolymer has a sufficient flexibility and thus is usable as a bioabsorbable surgical suture. Also when processed into a film, it has a sufficient strength. Also, it has an excellent biocompatibility and the effect of preventing cell adhesion, which makes it usable as a cell adhesion inhibitor (membrane).
摘要翻译：一种纤维和一种包含由通式（1）表示的嵌段共聚物并且重均分子量为25,000至500,000的膜，其中R表示氢或甲基; 1表示1以上的数; m，m'，n和n'相同或不同，分别表示0或1以上的数，条件是m + m'不为0，n + n'不为0。当加工成单丝，嵌段共聚物具有足够的柔韧性，因此可用作生物可吸收的手术缝合线。当加工成膜时，它具有足够的强度。此外，其具有优异的生物相容性和防止细胞粘附的效果，这使得其可用作细胞粘附抑制剂（膜）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式